WallStreetZenWallStreetZen

NASDAQ: HRTX
Heron Therapeutics Inc Earnings & Revenue

HRTX past revenue growth

How has HRTX's revenue growth performed historically?
Company
24.96%
Industry
187.71%
Market
18.28%
HRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HRTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HRTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HRTX earnings and revenue history

Current Revenue
$122.8M
Current Earnings
-$119.7M
Current Profit Margin
-97.4%

HRTX Return on Equity

Current Company
N/A
Current Industry
15.4%
Current Market
-8.4%

Be the first to know when HRTX announces earnings.

HRTX Return on Assets

Current Company
-53.1%
Current Industry
2.2%
HRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HRTX Return on Capital Employed

Current Company
-79.53%
Current Industry
17.7%
HRTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HRTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HRTX$122.84M-$115.89M-$119.70M+15.92%N/A
INZY$0.00-$66.87M-$68.17MN/AN/A
LXEON/AN/AN/AN/AN/A
TNYA$0.00-$115.98M-$127.67MN/AN/A
PRAX$1.93M-$136.33M-$137.57MN/AN/A

HRTX earnings dates

Next earnings date
Mar 21, 2024

Heron Therapeutics Earnings & Revenue FAQ

What were HRTX's earnings last quarter?

On Invalid Date, Heron Therapeutics (NASDAQ: HRTX) reported Q3 2023 earnings per share (EPS) of -$0.17, up 55.26% year over year. Total Heron Therapeutics earnings for the quarter were -$25.01 million. In the same quarter last year, Heron Therapeutics's earnings per share (EPS) was -$0.38.

If you're new to stock investing, here's how to buy Heron Therapeutics stock.

What was HRTX's earnings growth in the past year?

As of Q1 2024, Heron Therapeutics's earnings has grown year over year. Heron Therapeutics's earnings in the past year totalled -$119.70 million.

What is HRTX's earnings date?

Heron Therapeutics's earnings date is Invalid Date. Add HRTX to your watchlist to be reminded of HRTX's next earnings announcement.

What was HRTX's revenue last quarter?

On Invalid Date, Heron Therapeutics (NASDAQ: HRTX) reported Q3 2023 revenue of $31.43 million up 18.36% year over year. In the same quarter last year, Heron Therapeutics's revenue was $26.56 million.

What was HRTX's revenue growth in the past year?

As of Q1 2024, Heron Therapeutics's revenue has grown 24.96% year over year. This is 162.75 percentage points lower than the US Biotechnology industry revenue growth rate of 187.71%. Heron Therapeutics's revenue in the past year totalled $122.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.